Compounders Research Compare

Atossa Therapeutics, Inc.(ATOS)

Biotechnology · Seattle, WA

$2.450.00 (0.00%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative medicines. Their primary focus lies in addressing unmet medical needs in women's oncology, especially breast cancer, along with other conditions, within the United States. The company's flagship therapeutic candidate is oral (Z)-endoxifen. This compound, an active metabolite derived from tamoxifen, is currently undergoing Phase II clinical trials for both the treatment and prevention of breast cancer. Beyond this, Atossa is also advancing immunotherapy and chimeric antigen receptor (CAR) therapy programs. Established in 2008, the company adopted its current name, Atossa Therapeutics, Inc., in January 2020, having previously operated as Atossa Genetics Inc. It is headquartered in Seattle, Washington.

Seattle, WA

16 employees

www.atossatherapeutics.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Steven C. Quay

View full financials

Atossa Therapeutics (ATOS) Earnings Yield: History & Chart | TGMCharts

Earnings Yield: N/A

Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The earnings yield is N/A as of 2026-10-06T21:55:48.325Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:55:48.325Z.

Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.

Unrounded diluted TTM EPS · period ending 2026-06-30: -4.34
Quote price: 2.45

FMP input reference: 2c805ffacfcdae638738386c116dc6e6f159143ed75419b2c785d409d5d1ab78

P/E Ratio|FCF Yield|Dividend Yield|All Metrics

ATOS Earnings Yield Metrics

EARNINGS YIELD

N/A

ATOS Competitors' Earnings Yield

Atossa Therapeutics, Inc.

Current

Market Cap

$24.44M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

InspireMD, Inc.

Market Cap

$24.60M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Kyntra Bio, Inc.

Market Cap

$24.13M

Earnings Yield

N/A

TTM Avg

0.04%

3Y Avg

0.04%

5Y Avg

0.04%

ABVC BioPharma, Inc.

Market Cap

$25.22M

Earnings Yield

N/A

TTM Avg

0.06%

3Y Avg

0.06%

5Y Avg

0.06%

TherapeuticsMD, Inc.

Market Cap

$23.38M

Earnings Yield

N/A

TTM Avg

1.20%

3Y Avg

1.20%

5Y Avg

1.20%

Rein Therapeutics Inc.

Market Cap

$23.06M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LeonaBio, Inc.

Market Cap

$22.68M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Modular Medical, Inc.

Market Cap

$22.25M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Aytu BioPharma, Inc.

Market Cap

$22.00M

Earnings Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Tevogen Bio Holdings Inc.

Market Cap

$27.03M

Earnings Yield

N/A

TTM Avg

0.41%

3Y Avg

0.41%

5Y Avg

0.41%

NAME	MARKET CAP	EARNINGS YIELD	TTM	3Y	5Y
Atossa Therapeutics, Inc. (ATOS)	$24.44M	N/A	N/A	N/A	N/A
InspireMD, Inc. (NSPR)vs ›	$24.60M	N/A	N/A	N/A	N/A
Kyntra Bio, Inc. (KYNB)vs ›	$24.13M	N/A	0.04%	0.04%	0.04%
ABVC BioPharma, Inc. (ABVC)vs ›	$25.22M	N/A	0.06%	0.06%	0.06%
TherapeuticsMD, Inc. (TXMD)vs ›	$23.38M	N/A	1.20%	1.20%	1.20%
Rein Therapeutics Inc. (RNTX)vs ›	$23.06M	N/A	N/A	N/A	N/A
LeonaBio, Inc. (LONA)vs ›	$22.68M	N/A	N/A	N/A	N/A
Modular Medical, Inc. (MODD)vs ›	$22.25M	N/A	N/A	N/A	N/A
Aytu BioPharma, Inc. (AYTU)vs ›	$22.00M	N/A	N/A	N/A	N/A
Tevogen Bio Holdings Inc. (TVGN)vs ›	$27.03M	N/A	0.41%	0.41%	0.41%

Earnings Yield vs P/E Ratio

Earnings Yield

N/A

EPS ÷ Price

P/E Ratio

N/A

Price ÷ EPS

Formula: Earnings Yield = (EPS / Price) × 100

Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.

How earnings yield is used:

It expresses earnings relative to share price as a percentage
It can be compared with FCF yield and dividend yield
It can be compared with bond yields because both are percentages
It is mathematically the inverse of the P/E ratio

Earnings Yield Formula & Definition

Earnings Yield = EPS (TTM) / Share Price

Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

P/E Ratio FCF Yield Dividend Yield All Metrics